Patients Empowered With Digital Scripts: ScalaMed (PEDS)

Holdsworth House Medical Practice

Status: Withdrawn

Conditions: Technology

Treatments: Other: ScalaMed ePrescription application

Study type: Observational

Funder types: Other

Identifiers

NCT03479034

SCALA001

Details and patient eligibility

About

A prospective qualitative and quantitative controlled study, exploring the impact of patient centred digital prescriptions on health, in patients with chronic health conditions.

Full description

ScalaMed is an innovative new consumer centred solution for securing prescriptions through a blockchain solution - a cryptographic distributed database, that can give consumer access to their prescriptions at all times. It aims to solve interoperability challenges that exist in healthcare, by creating a ledger of prescriptions, and giving consumers access to this information to own and share as they need. The solution will be accessed through an application available on a smart phone, will be fully compliant with security and privacy laws, and will be made available to consumers, clinicians, and pharmacies enrolled in this study free of charge. The system also allows patients to monitor the usage of their prescriptions - eg when they need a new one, and allows them to choose how and where they want to use their prescriptions like with paper.

This study will explore whether empowering consumers with their digital prescriptions in a digital format through a blockchain based methodology of storing and accessing their data, will improve the flow of clinically important information, improve the frequency of data sharing, improve the self-management of the patient, improve adherence to treatments, reduce interactions and adverse events associated with medications, reduce the burden on clinical practice, improve efficiency, reduce the amount of paper, increase consumer engagement and improve patient satisfaction.

Sex: All

Ages: 18 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ages 18-85
• Cognitively able to understand instructions and care for themselves
• Lives in the community (not institutionalised)
• Owner of a smartphone and able to use Apps
• On 3 or more chronic prescription medications
• Informed consent as documented by signature (Appendix Informed Consent Form)
• Has had experience with prescriptions in Australia for at least 1 year
• For the clinicians - any clinician who is using the ScalaMed prescription system in the Holdsworth House
• For pharmacists - who are utilising the ScalaMed system in one of the four clinics

Exclusion criteria

• Known or suspected non-compliance, drug or alcohol abuse
• Inability to follow the procedures of the study due to language problems, psychological disorders, dementia of the participant
• Previous enrolment into the current study

Trial design

0 participants in 1 patient group

Group 1

Description:

* Ages 18-85 * Cognitively able to understand instructions and care for themselves * Lives in the community (not institutionalised) * Owner of a smartphone and able to use Apps * On 3 or more chronic prescription medications * Has had experience with prescriptions in Australia for at least 1 year * Current patient attending Holdsworth House Medical Practice Willing to use the ScalaMed ePrescription application

Treatment:

Other: ScalaMed ePrescription application